Recent perspective on coronary bifurcation intervention: statement of the "Bifurcation Club in KOKURA"

Yoshinobu Murasato1, Yutaka Hikichi, Sunao Nakamura

  • 1Department of Cardiovascular Medicine, Heart Center, New Yukuhashi Hospital, Dojoji, Japan. murasato@shinyukuhashihospital.or.jp

Insights

Treating coronary artery bifurcation lesions is complex, even with drug-eluting stents. Restenosis and stent thrombosis are linked to blood flow disturbances, highlighting the need for techniques that restore natural coronary anatomy and physiology.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Interventional Cardiology

Background:

  • Coronary artery bifurcation lesions present significant treatment challenges, persisting despite advances like drug-eluting stents.
  • Restenosis and stent thrombosis are associated with geometrical factors and, crucially, rheological disturbances at the bifurcation site.

Purpose of the Study:

  • To summarize the global consensus on coronary bifurcation lesion management from the Asian and European Bifurcation Clubs.
  • To provide a scientific perspective on bifurcation anatomy, physiology, and pathology to guide intervention strategies.

Main Methods:

  • Review and synthesis of expert consensus from international bifurcation clubs.
  • Analysis of basic science principles related to coronary bifurcation hemodynamics and pathology.

Main Results:

  • Low wall shear stress and turbulent flow at bifurcations contribute to atherosclerosis and stent thrombosis.
  • Factors like jailed struts and metal overlap exacerbate these risks.

Conclusions:

  • Future coronary bifurcation interventions must aim to restore both the anatomical structure and physiological flow patterns.
  • A comprehensive understanding of bifurcation hemodynamics is essential for developing optimal intervention techniques.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...